Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Regina Day

Physician Assistant Philadelphia, PA Physician Assistant

NPI 1720747850 CMS profile 11376294

333 Cottman Ave, Philadelphia, PA 19111

Open in the dashboard

General payments

$5,177

179 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Regina Day of Philadelphia, PA is reported in the CMS Open Payments database as having received $5,177 across 179 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $579 17
2024 General $1,014 28
2023 General $1,578 69
2022 General $2,006 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Regina Day
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Regina Day were reported at $579. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Regina Day Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $2,006 $155 $48–$522 $149
2023 $1,578 $167 $52–$557 $160
2024 $1,014 $178 $55–$600 $164
2025 $579 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Sun Pharmaceutical Industries Inc. $624 16 payments
  2. Janssen Biotech, Inc. $572 18 payments
  3. AbbVie, Inc. $498 21 payments
  4. E.R. Squibb & Sons, L.L.C. $471 17 payments
  5. Incyte Corporation $451 12 payments
  6. Regeneron Healthcare Solutions, Inc. $365 12 payments
  7. Genzyme Corporation $322 12 payments
  8. Lilly USA, LLC $261 12 payments
  9. Journey Medical Corporation $239 2 payments
  10. Almirall LLC $193 8 payments
  11. Other $1,181 49 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $4,804 174 payments
  2. Education $373 5 payments
Products named General payments · program years 2022–2025
  1. TREMFYA $703 20 payments
  2. DUPIXENT Immunology $524 20 payments
  3. SOTYKTU $471 17 payments
  4. OPZELURA $451 12 payments
  5. DUPIXENT Inflammation And Immunology $313 10 payments
  6. ILUMYA $287 10 payments
  7. RINVOQ $277 5 payments
  8. TALTZ $261 12 payments
  9. Winlevi $224 3 payments
  10. OLUMIANT $221 10 payments
  11. Other $1,813 81 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

514

Median for Dermatology: 534

Drug cost

$12,569

Median for Dermatology: $67,151

Branded share of claims

2.9%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Fluorouracil Generic 42 $2,458
Ketoconazole Generic 113 $1,591
Tacrolimus Generic 17 $1,499
Clobetasol Propionate Generic 46 $1,470
Azelaic Acid Generic 13 $1,338
Metronidazole Generic 18 $1,075
Doxycycline Hyclate Generic 36 $743
Betamethasone Dipropionate Generic 21 $668
Ciclopirox Generic 15 $494
Triamcinolone Acetonide Generic 70 $406

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$216,991

Medicare's payments for the services billed

Medicare patients

976

Average age 75

Services billed

6,225

543 women, 433 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 45%
Diabetes 20%
Ischemic heart disease 19%
Chronic kidney disease 19%
Cancer 17%
Atrial fibrillation 14%
Depression 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 14 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $234
$234 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $144
$144 — —
RINVOQ
  • AbbVie, Inc. $135
$135 — —
Otezla
  • Amgen Inc. $87
$87 — —
YCANTH
  • VERRICA PHARMACEUTICALS INC. $62
$62 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 14 in the dashboard with a free account

Records

179 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record